Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2019, OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ________________ Commission File Number: 1-13595 Mettler Toledo International Inc _______________________________________ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2019, OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ________________ Commission File Number: 1-13595 Mettler Toledo International Inc and Im Langacher, P.O. Box MT-100 CH 8606 Gr ...

[PART I. FINANCIAL INFORMATION](index=2&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) [Item 1. Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) Presents unaudited interim consolidated financial statements for Q1 2019 and 2018, covering operations, balance sheets, cash flows, and detailed notes [Interim Consolidated Statements of Operations and Comprehensive Income](index=3&type=section&id=Interim%20Consolidated%20Statements%20of%20Operations%20and%20Comprehensive%20Income) Total net sales increased to **$679.5 million** in Q1 2019, with net earnings rising to **$111.8 million** and diluted EPS reaching **$4.42** Consolidated Statements of Operations Highlights (Q1 2019 vs Q1 2018) | Metric | Three months ended March 31, 2019 (thousand) | Three months ended March 31, 2018 (thousand) | | :--- | :--- | :--- | | **Total Net Sales** | $679,452 | $660,821 | | **Gross Profit** | $388,319 | $374,933 | | **Earnings Before Taxes** | $125,676 | $117,439 | | **Net Earnings** | $111,805 | $93,304 | | **Diluted EPS** | $4.42 | $3.58 | [Interim Consolidated Balance Sheets](index=4&type=section&id=Interim%20Consolidated%20Balance%20Sheets) Total assets were **$2.64 billion**, liabilities **$2.07 billion**, and shareholders' equity **$561.8 million** as of March 31, 2019, impacted by repurchases Consolidated Balance Sheet Highlights | Metric | March 31, 2019 (thousand) | December 31, 2018 (thousand) | | :--- | :--- | :--- | | **Total Current Assets** | $969,384 | $1,045,860 | | **Total Assets** | $2,636,697 | $2,618,847 | | **Total Current Liabilities** | $707,964 | $734,434 | | **Total Liabilities** | $2,074,947 | $2,028,784 | | **Total Shareholders' Equity** | $561,750 | $590,063 | [Interim Consolidated Statements of Cash Flows](index=6&type=section&id=Interim%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash from operating activities increased to **$98.8 million** in Q1 2019, while financing activities used **$136.2 million**, resulting in a **$51.6 million** net decrease in cash Consolidated Statements of Cash Flows Highlights (Q1 2019 vs Q1 2018) | Metric | Three months ended March 31, 2019 (thousand) | Three months ended March 31, 2018 (thousand) | | :--- | :--- | :--- | | **Net Cash from Operating Activities** | $98,795 | $76,564 | | **Net Cash used in Investing Activities** | ($17,530) | ($22,463) | | **Net Cash used in Financing Activities** | ($136,199) | ($107,683) | | **Net Decrease in Cash** | ($51,630) | ($49,738) | [Notes to the Interim Consolidated Financial Statements](index=7&type=section&id=Notes%20to%20the%20Interim%20Consolidated%20Financial%20Statements) Detailed notes explain accounting policies, including revenue recognition, segment reporting, debt, share repurchases, and the adoption of ASC 842 - The company is a leading global supplier of precision instruments and services, with primary manufacturing in China, Germany, Switzerland, the UK, and the US[18](index=18&type=chunk) Revenue by Geographic Destination (Q1 2019 vs Q1 2018) | Region | 2019 (thousand) | 2018 (thousand) | | :--- | :--- | :--- | | Americas | $258,631 | $252,279 | | Europe | $209,555 | $205,840 | | Asia / Rest of World | $211,266 | $202,702 | | **Total** | **$679,452** | **$660,821** | Revenue by Product Category (Q1 2019 vs Q1 2018) | Category | 2019 (thousand) | 2018 (thousand) | | :--- | :--- | :--- | | Laboratory | $359,732 | $345,159 | | Industrial | $271,320 | $262,656 | | Retail | $48,400 | $53,006 | | **Total** | **$679,452** | **$660,821** | - On January 1, 2019, the company adopted the new lease accounting standard ASC 842, recognizing a **$92.7 million** right-of-use asset and a **$93.5 million** lease liability[88](index=88&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=24&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses Q1 2019 financial results, highlighting **3%** net sales growth (7% local currency), gross profit, operating expenses, liquidity, and capital resources [Results of Operations – Consolidated](index=24&type=section&id=Results%20of%20Operations%20%E2%80%93%20Consolidated) Consolidated net sales grew **3%** (7% local currency) to **$679.5 million**, with gross profit margin improving to **57.2%** and net earnings increasing to **$111.8 million** Net Sales Growth by Geography (Q1 2019 YoY) | Region | Growth in U.S. Dollars | Growth in Local Currency | | :--- | :--- | :--- | | Americas | 3% | 3% | | Europe | 2% | 9% | | Asia/Rest of World | 4% | 9% | Net Sales Growth by Product Category (Q1 2019 YoY, Local Currency) | Product Category | Local Currency Growth | | :--- | :--- | | Laboratory | 8% | | Industrial | 8% | | Food Retailing | -5% | - The company estimates an annualized cost increase of approximately **$25 million** from U.S. tariffs on products imported from China and is implementing actions to mitigate the effects[112](index=112&type=chunk) [Results of Operations – by Operating Segment](index=26&type=section&id=Results%20of%20Operations%20%E2%80%93%20by%20Operating%20Segment) Operating segments showed varied performance, with Chinese Operations leading with **13%** local currency sales growth, followed by Western European Operations at **9%** - U.S. Operations: Net sales to external customers grew **2%**, driven by strong laboratory product growth despite a decline in food retailing[119](index=119&type=chunk) - Swiss Operations: Net sales to external customers increased **7%** in local currency, driven by strong growth across most product categories[122](index=122&type=chunk) - Western European Operations: Net sales to external customers grew **9%** in local currency, with strong performance in core industrial, laboratory balances, and process analytics[125](index=125&type=chunk) - Chinese Operations: Net sales to external customers increased **13%** in local currency, reflecting strong growth in both laboratory and industrial products[129](index=129&type=chunk) [Liquidity and Capital Resources](index=28&type=section&id=Liquidity%20and%20Capital%20Resources) Liquidity remains strong with cash from operations increasing to **$98.8 million**, total debt at **$1.06 billion**, and **$186.3 million** spent on share repurchases - Cash provided by operating activities increased to **$98.8 million** for the three months ended March 31, 2019, up from **$76.6 million** in the prior year period, due to higher net earnings and lower working capital outflow[135](index=135&type=chunk) - As of March 31, 2019, the company had total debt of **$1.06 billion** and **$575.2 million** of availability under its Credit Agreement[66](index=66&type=chunk)[139](index=139&type=chunk) - In April 2019, the company entered an agreement to issue **$75 million** of ten-year Senior Notes with a fixed interest rate of **3.91%**, maturing in June 2029[141](index=141&type=chunk) - The share repurchase program has **$1.9 billion** of remaining availability as of March 31, 2019, with **290,429 shares** repurchased for **$186.3 million** in Q1 2019[146](index=146&type=chunk)[147](index=147&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=31&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) No material changes were reported regarding market risk disclosures compared to the 2018 Form 10-K - As of March 31, 2019, there were no material changes to the market risk information previously disclosed in the company's 2018 Form 10-K[154](index=154&type=chunk) [Item 4. Controls and Procedures](index=31&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded disclosure controls and procedures were effective, with modifications to internal controls for the adoption of ASC 842 - The CEO and CFO concluded that the company's disclosure controls and procedures are effective as of the end of the period covered by this report[155](index=155&type=chunk) - The company modified its processes and internal controls over financial reporting (ICFR) due to the adoption of the new lease accounting standard ASC 842 on January 1, 2019[156](index=156&type=chunk) [PART II. OTHER INFORMATION](index=32&type=section&id=PART%20II.%20OTHER%20INFORMATION) [Item 1. Legal Proceedings](index=32&type=section&id=Item%201.%20Legal%20Proceedings) The company reported no material legal proceedings during the quarter - The company reports no legal proceedings[158](index=158&type=chunk) [Item 1A. Risk Factors](index=32&type=section&id=Item%201A.%20Risk%20Factors) No material changes were reported regarding risk factors compared to the 2018 Form 10-K - No material changes from the risk factors disclosed in the 2018 Form 10-K were reported for the quarter[158](index=158&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=32&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company repurchased **290,429 shares** for **$186.3 million** in Q1 2019, with **$1.9 billion** remaining under the program Issuer Purchases of Equity Securities (Q1 2019) | Period | Total Shares Purchased | Average Price Paid per Share ($) | | :--- | :--- | :--- | | January 2019 | 105,963 | $575.72 | | February 2019 | 92,362 | $660.49 | | March 2019 | 92,104 | $697.42 | | **Total** | **290,429** | **$641.27** | - As of March 31, 2019, **$1.9 billion** remained available for repurchase under the company's share repurchase program[159](index=159&type=chunk) [Item 6. Exhibits](index=32&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including CEO and CFO certifications and XBRL data

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-13595 Mettler-Toledo International Inc. 1900 Polaris Parkway Columbus, OH 43240 and Im Langacher 44 CH 8606 Greifensee, Switzerland ( ...